Results 1 to 10 of about 14,072,748 (310)

Acupuncture for chronic hepatitis B

Cochrane Database of Systematic Reviews, 2018
Chronic hepatitis B is a liver disease associated with high morbidity and mortality. Chronic hepatitis B requires long-term management aiming to reduce the risks of hepatocellular inflammatory necrosis, liver fibrosis, decompensated liver cirrhosis, liver failure, and liver cancer, as well as to improve health-related quality of life.
Kong, De Zhao, Liang, Ning, Yang, Guan Lin, Zhang, Zhe, Liu, Yue, Yang, Ye, Liu, Yu Xi, Wang, Qi Ge, Zhang, Fan, Zhang, Hui Yong, Nikolova, Dimitrinka, Jakobsen, Janus C.; id_orcid 0000-0002-3642-2120, Gluud, Christian, Liu, Jian Ping   +13 more
openaire   +4 more sources

Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report

Journal of Medical Case Reports, 2018
Background Hepatitis E virus infection usually causes an acute and self-resolving hepatitis. In areas where chronic hepatitis B virus infection is prevalent, acute hepatitis E virus superinfection on chronic hepatitis B virus infection occurs ...
Chau-Ting Yeh, Christopher Sung-Huan Yeh, Yu-De Chu, Yang-Jen Chiang   +3 more
doaj   +1 more source

Treatment of Chronic Hepatitis B

Antiviral Therapy, 2007
Hepatitis B virus (HBV) infection is the leading cause of chronic liver disease and hepatocellular carcinoma worldwide. Approximately 350 million individuals are infected with HBV and >500,000 deaths per year can be attributed to HBV. Although universal vaccination has reduced HBV incidence in many countries, it still remains a major public health ...
Rohit, Loomba, T Jake, Liang
openaire   +5 more sources

The Relationship Between Hepatic Activity Index and Serum Tumor Necrosis Factor Alpha Levels in Patients with Chronic Active Hepatitis-B and Chronic Active Hepatitis-C

Medicine Science, 2015
In the present study, we investigated the relationship between serum TNF-α levels and hepatic activity in liver biopsies of chronic hepatitis B and C patients.The study was performed on 30 chronic hepatitis B patients, 25 chronic hepatitis C ...
Yilmaz Bilgic, Murat Harputluoglu, Bulent Yaprak, Mehmet Burak Dal, Mehmet Bugra Bozan, Abdurrahman Sahin, Fatih Mehmet Yazar, Yasir Furkan Cagin, Nihat Okcu   +8 more
doaj   +1 more source

Depressive symptoms and cognitive dysfunctions in patients with chronic hepatitis B [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2015
Introduction. Pronounced symptoms of depression and disorders of cognitive functions can be observed in patients with chronic hepatitis B. Objective.
Pavić Slađana, Švirtlih Neda, Delić Dragan, Radovanović-Špurnić Aleksandra   +3 more
doaj   +1 more source

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance

Viruses, 2023
Hepatitis B surveillance is essential to achieving Canada’s goal of eliminating hepatitis B by 2030. Hepatitis B rates, association of infection with vaccine age-eligibility, and risk factors were analyzed among 1,401,603 first-time Canadian blood donors
Sheila F. O’Brien, Cassandra N. Reedman, Carla Osiowy, Shelly Bolotin, Qi-Long Yi, Lillian Lourenço, Antoine Lewin, Mawuena Binka, Niamh Caffrey, Steven J. Drews   +9 more
doaj   +1 more source

Bicyclol for chronic hepatitis B

Cochrane Database of Systematic Reviews, 2006
Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis B. Until now, systematic reviews of bicyclol therapy have not been performed.To study the benefits and harms of bicyclol for patients with chronic hepatitis B.We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (July 2005), The Cochrane Central
Wu, Taixiang, Xie, Lingxia, Liu, Guan Jian, Hao, Baoqing, Harrison, Roger A   +4 more
openaire   +3 more sources

Baseline quantitative HBcAb strongly predicts undetectable HBV DNA and RNA in chronic hepatitis B patients treated with entecavir for 10 years

Scientific Reports, 2021
The predictive effect of quantitative anti-hepatitis B core on double-negative HBV DNA and RNA remains unstudied. We observed dynamic changes in this measure in chronic hepatitis B patients receiving entecavir for 10 years, evaluating its predictive ...
Xi Zhang, Xiaocui An, Lei Shi, Xueliang Yang, Yunru Chen, Xiaojing Liu, Jianzhou Li, Feng Ye, Shumei Lin   +8 more
doaj   +1 more source

Immunopathogenesis of chronic hepatitis B

World Journal of Gastroenterology, 2014
Chronic hepatitis B (CHB) is a widespread infectious disease with unfavorable outcomes and life-threatening consequences for patients, in spite of modern vaccination and antiviral treatment modalities. Cutting-edge experimental approaches have demonstrated key pathways that involve cross-talk between viral particles and host immune cells.
Balmasova I.P., Yushchuk N.D., Mynbaev O.A., Alla N.R., Malova E.S., Shi Z., Gao C.-L.   +6 more
openaire   +4 more sources

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy

mBio
The persistence of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is a key obstacle for HBV cure. This study aims to comprehensively assess the effect of interferon (IFN) and small-interfering RNA (siRNA) combination on the cccDNA ...
Kongying Hu, Wenjing Zai, Mingzhu Xu, Haiyu Wang, Xinluo Song, Chao Huang, Jiangxia Liu, Juan Chen, Qiang Deng, Zhenghong Yuan, Jieliang Chen   +10 more
doaj   +1 more source